Published in J Pharmacol Exp Ther on December 07, 2012
Pharmacokinetic correlates of the effects of a heroin vaccine on heroin self-administration in rats. PLoS One (2014) 1.39
Dynamic vaccine blocks relapse to compulsive intake of heroin. Proc Natl Acad Sci U S A (2013) 1.24
Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens. J Med Chem (2013) 0.86
Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats. PLoS One (2014) 0.85
Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccines. Anal Bioanal Chem (2014) 0.84
Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers. Bioconjug Chem (2015) 0.80
A conjugate vaccine attenuates morphine- and heroin-induced behavior in rats. Int J Neuropsychopharmacol (2014) 0.79
Synthesis and immunological effects of heroin vaccines. Org Biomol Chem (2014) 0.78
Biologics to treat substance use disorders: Current status and new directions. Hum Vaccin Immunother (2016) 0.75
Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice. J Pharmacol Exp Ther (2016) 0.75
Development of a Clinically-Viable Heroin Vaccine. J Am Chem Soc (2017) 0.75
Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther (2011) 2.33
Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry (2005) 2.18
Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model. Psychopharmacology (Berl) (2000) 1.83
Changes in heroin self-administration by a rhesus monkey after morphine immunisation. Nature (1974) 1.81
A second-generation vaccine protects against the psychoactive effects of cocaine. Proc Natl Acad Sci U S A (2001) 1.78
Opiate addiction in China: current situation and treatments. Addiction (2006) 1.78
Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans. Biol Psychiatry (2010) 1.75
A vaccine strategy that induces protective immunity against heroin. J Med Chem (2011) 1.47
Improving drug addiction treatment in China. Addiction (2007) 1.45
Pharmacokinetics of heterologous and homologous immunoglobulin G, F(ab')2 and Fab after intravenous administration in the rat. J Pharm Pharmacol (1997) 1.38
A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents. Vaccine (2006) 1.35
Evidence from opiate binding studies that heroin acts through its metabolites. Life Sci (1983) 1.30
The pharmacological treatment of opioid addiction--a clinical perspective. Eur J Clin Pharmacol (2010) 1.30
Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans. Psychopharmacology (Berl) (1999) 1.24
Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine. Exp Clin Psychopharmacol (2008) 1.20
Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available. Curr Psychiatry Rep (2010) 1.16
Species difference of esterase expression and hydrolase activity in plasma. J Pharm Sci (2012) 1.16
Combined active and passive immunization enhances the efficacy of immunotherapy against nicotine in rats. J Pharmacol Exp Ther (2008) 1.16
An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia. J Pharmacol Exp Ther (2012) 1.13
Pharmacokinetics and cytokine production in heroin and morphine-treated mice. Int J Immunopharmacol (2000) 1.08
A morphine/heroin vaccine with new hapten design attenuates behavioral effects in rats. J Neurochem (2011) 1.08
mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine. Biochem Pharmacol (2001) 1.05
Tissue-dependent effects of immunization with a nicotine conjugate vaccine on the distribution of nicotine in rats. Int Immunopharmacol (2003) 1.04
Increased locomotor activity induced by heroin in mice: pharmacokinetic demonstration of heroin acting as a prodrug for the mediator 6-monoacetylmorphine in vivo. J Pharmacol Exp Ther (2009) 1.03
Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats. Vaccine (2012) 1.03
Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats. Biochem Pharmacol (2011) 1.01
Opioid dependence: rationale for and efficacy of existing and new treatments. Clin Infect Dis (2006) 1.00
Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Curr Clin Pharmacol (2006) 0.99
Species differences in hydrolysis of isocarbacyclin methyl ester (TEI-9090) by blood esterases. Biochem Pharmacol (1995) 0.98
Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects. J Clin Psychopharmacol (2000) 0.98
Human erythrocyte but not brain acetylcholinesterase hydrolyses heroin to morphine. Clin Exp Pharmacol Physiol (1999) 0.97
The pharmacologic effects of heroin in relationship to its rate of biotransformation. J Pharmacol Exp Ther (1960) 0.96
Combined active and passive immunization against nicotine: minimizing monoclonal antibody requirements using a target antibody concentration strategy. Int Immunopharmacol (2011) 0.91
Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts. Clin Pharmacol Ther (2003) 0.88
Stability of heroin, 6-monoacetylmorphine, and morphine in biological samples and validation of an LC-MS assay for delayed analyses of pharmacokinetic samples in rats. J Pharm Biomed Anal (2012) 0.86
Mecamylamine blocks the development of tolerance to nicotine in rats: implications for the mechanisms of tolerance. Psychopharmacology (Berl) (1999) 0.86
Effect of repeated administrations of heroin, naltrexone, methadone, and alcohol on morphine glucuronidation in the rat. Psychopharmacology (Berl) (2005) 0.85
Effects of naloxone on heroin-, amphetamine- and caffeine-stimulated locomotor activity in the rat. Pharmacol Biochem Behav (1985) 0.81
Interactions between morphine and the morphine-glucuronides measured by conditioned place preference and locomotor activity. Pharmacol Biochem Behav (2009) 0.79
Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients. Drug Alcohol Depend (2005) 0.78
Heroin: analgesia, toxicity and disposition in the mouse. Eur J Pharmacol (1982) 0.78
Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat Genet (1996) 6.06
Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat Genet (1998) 2.32
Preferences and practices among renters regarding smoking restrictions in apartment buildings. Tob Control (2003) 2.13
Sequence analysis of the cloned streptococcal cell surface antigen I/II. FEBS Lett (1989) 2.11
Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp Clin Psychopharmacol (1999) 2.01
Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose- and affinity-response relationships. Drug Metab Dispos (2005) 1.47
Pharmacodynamic effects of cotinine in abstinent cigarette smokers. Clin Pharmacol Ther (1994) 1.45
Comparison of the clinic microscopy laboratory with the cytopathology laboratory in the detection of malignant cells in body fluids. Am J Clin Pathol (1994) 1.38
Enhanced immunogenicity of a bivalent nicotine vaccine. Int Immunopharmacol (2008) 1.36
Mullerian duct anomalies: from diagnosis to intervention. Br J Radiol (2009) 1.32
Radiological features of synovial cell sarcoma. Br J Radiol (2008) 1.30
Altered disposition of repeated nicotine doses in rats immunized against nicotine. Nicotine Tob Res (1999) 1.30
Active immunization alters the plasma nicotine concentration in rats. J Pharmacol Exp Ther (1997) 1.23
Muscarinic acetylcholine receptors. Peptide sequencing identifies residues involved in antagonist binding and disulfide bond formation. J Biol Chem (1990) 1.22
Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy. Neurology (2008) 1.19
Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain. Int J Immunopharmacol (2000) 1.19
Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities. Biochem Pharmacol (2011) 1.18
An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia. J Pharmacol Exp Ther (2012) 1.13
Immunization of rats reduces nicotine distribution to brain. Psychopharmacology (Berl) (1999) 1.08
Staining for Bcl-2 protein helps to distinguish benign from malignant lymphoid aggregates in bone marrow biopsies. Mod Pathol (1994) 1.06
Tissue-dependent effects of immunization with a nicotine conjugate vaccine on the distribution of nicotine in rats. Int Immunopharmacol (2003) 1.04
Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex. Clin Pharmacol Ther (2012) 1.04
Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats. Vaccine (2012) 1.03
Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats. Biochem Pharmacol (2011) 1.01
Tricyclic antidepressant poisoning. Management of arrhythmias. Med Toxicol (1987) 1.00
Reversal of flecainide-induced ventricular arrhythmia by hypertonic sodium bicarbonate in dogs. Am J Emerg Med (1995) 0.97
Biomarkers of tobacco exposure or harm: application to clinical and epidemiological studies. 25-26 October 2001, Minneapolis, Minnesota. Nicotine Tob Res (2003) 0.96
Carvedilol affects the physiological and behavioral response to smoked cocaine in humans. Drug Alcohol Depend (2000) 0.96
Radiological imaging features of non-uterine leiomyosarcoma. Br J Radiol (2007) 0.96
Myocardial injury after phenylpropanolamine ingestion. Br Heart J (1982) 0.93
Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome. Pharmacol Biochem Behav (2001) 0.92
Enhanced intestinal adenomatous polyp formation in Pms2-/-;Min mice. Cancer Res (1998) 0.91
Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in rats. J Pharmacol Exp Ther (2003) 0.91
Safety of cotinine in humans: physiologic, subjective, and cognitive effects. Pharmacol Biochem Behav (1997) 0.91
Using PharmGKB to train text mining approaches for identifying potential gene targets for pharmacogenomic studies. J Biomed Inform (2012) 0.90
High-level secretion of two antibody single chain Fv fragments by Pichia pastoris. J Immunol Methods (1997) 0.90
The imaging features of gastrointestinal stromal tumours. Eur J Radiol (2006) 0.90
Large scale production and purification of paraquat and desipramine monoclonal antibodies and their Fab fragments. Int J Immunopharmacol (1988) 0.89
Inhibition of nicotine-induced seizures in rats by combining vaccination against nicotine with chronic nicotine infusion. Exp Clin Psychopharmacol (2001) 0.88
Effects of phenytoin on cocaine self-administration in humans. Drug Alcohol Depend (1999) 0.86
Spontaneous perforation of pyometra due to acute necrotising endometritis. J Obstet Gynaecol (2011) 0.86
Effect of hypertonic sodium bicarbonate on encainide overdose. Am J Cardiol (1986) 0.84
Effects of recombinant drug-specific single chain antibody Fv fragment on [3H]-desipramine distribution in rats. Biochem Pharmacol (1996) 0.84
The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memory. Epilepsy Behav (2012) 0.84
Synovial osteochondromatosis: the spectrum of imaging findings. Australas Radiol (2005) 0.83
Hypertonic sodium bicarbonate partially reverses QRS prolongation due to flecainide in rats. Life Sci (1989) 0.83
Failure of absorption of gabapentin after rectal administration. Epilepsia (1997) 0.83
Effects of cotinine on cigarette self-administration. Psychopharmacology (Berl) (1998) 0.83
Effects of labetalol treatment on the physiological and subjective response to smoked cocaine. Pharmacol Biochem Behav (2000) 0.81
Physical assessment and differential diagnosis of the poisoned patient. Med Toxicol (1987) 0.81
Methodological issues in the administration of multiple doses of smoked cocaine-base in humans. Pharmacol Biochem Behav (1994) 0.81
Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control study. Neurology (2010) 0.81
Flu-like symptoms associated with fluoxetine overdose: a case report. J Toxicol Clin Toxicol (1989) 0.80
Changes in maternal and fetal nicotine distribution after maternal administration of monoclonal nicotine-specific antibody to rats. Int Immunopharmacol (2006) 0.80
Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors. Epilepsy Res (2001) 0.80
Individual variability in the blood pressure response to intravenous phenylpropanolamine: a pharmacokinetic and pharmacodynamic investigation. Clin Pharmacol Ther (1989) 0.79
Propranolol antagonism of phenylpropanolamine-induced hypertension. Clin Pharmacol Ther (1985) 0.79
Lactulose in vincristine-induced constipation. Med J Aust (1977) 0.79
Effects of dynorphin A(1-13) on opiate withdrawal in humans. Psychopharmacology (Berl) (1998) 0.78
Effects of carbamazepine on acute responses to smoked cocaine-base in human cocaine users. Psychopharmacology (Berl) (1991) 0.78
Localization and structure of the muscarinic receptor ligand binding site. Trends Pharmacol Sci (1989) 0.78
Leiomyosarcoma of the distal femur in a patient with a history of bilateral retinoblastoma: a case report and review of the literature. Skeletal Radiol (2003) 0.77
Reversal of desipramine toxicity in rats using drug-specific antibody Fab' fragment: effects on hypotension and interaction with sodium bicarbonate. J Pharmacol Exp Ther (1992) 0.77
Pharmacokinetics and toxicity of high-dose human alpha 1-acid glycoprotein infusion in the rat. J Pharm Sci (1987) 0.77
Redistribution and enhanced urinary excretion of 2,2',4,4',5,5'-hexachlorobiphenyl (HCB) in rats using HCB-specific IgG and Fab fragments. Biochem Pharmacol (1994) 0.77
Novel isoforms of CaBP 33/37 (annexin V) from mammalian brain: structural and phosphorylation differences that suggest distinct biological roles. Biochim Biophys Acta (1992) 0.77
Bacterial expression and characterization of an anti-desipramine single-chain antibody fragment. Int J Immunopharmacol (1996) 0.76
Hemoperfusion for imipramine overdose: elimination of active metabolites. J Toxicol Clin Toxicol (1982) 0.76
Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver. J Pharmacol Exp Ther (1995) 0.76
Cotinine: effects with and without nicotine. Psychopharmacology (Berl) (1998) 0.76
mu-opioid receptor regulates CFTR coexpressed in Xenopus oocytes in a cAMP independent manner. Brain Res Mol Brain Res (1997) 0.76
Myocardial necrosis due to intraperitoneal administration of phenylpropanolamine in rats. Fundam Appl Toxicol (1987) 0.76
Determination of the in vivo antigen-antibody affinity constant from the redistribution of desipramine in rats following administration of a desipramine-specific monoclonal antibody. Biochem Pharmacol (1991) 0.76
Smoked cocaine self-administration in females. Psychopharmacology (Berl) (1996) 0.76
Variation in human plasma cholinesterase activity during low-dose cocaine administration. J Toxicol Clin Toxicol (1998) 0.76
Epigastric pain and a left upper quadrant mass in an elderly woman. Postgrad Med J (1997) 0.75
Potentiation of warfarin anticoagulation by sulfisoxazole. Arch Intern Med (1980) 0.75
Cloning, expression, and purification of an anti-desipramine single chain antibody in NS/O myeloma cells. J Pharm Sci (1995) 0.75
Effects of alpha-1-acid glycoprotein administration on propranolol binding and beta blockade in rats. Biochem Pharmacol (1989) 0.75
Drug-specific F(ab')2 fragment reduces desipramine cardiotoxicity in rats. Int J Immunopharmacol (1991) 0.75
A capillary GC-MS method for analysis of phenytoin and [13C3]-phenytoin from plasma obtained from pulse dose pharmacokinetic studies. J Pharm Biomed Anal (1998) 0.75
Clinical features and consequences of seizures due to cyclic antidepressant overdose. Am J Emerg Med (1989) 0.75
Rhabdoid cells in peritoneal fluid. A case report. Acta Cytol (1997) 0.75
Encapsulated alkali ingestion has a characteristic endoscopic appearance. Gastrointest Endosc (1986) 0.75
Clara Chase Leach, M.D.: beloved physician. Am Baptist Q (1999) 0.75
A new perspective on the psychological effects of environmental barriers. Rehabil Lit (1977) 0.75
Therapeutic doses of phenylpropanolamine increase supine systolic blood pressure. Int J Obes (1985) 0.75
Internal oblique hematoma: an alternative computed tomography diagnosis for flank pain. J Emerg Med (2001) 0.75
The effect of phenylpropanolamine on blood pressure during upright bicycle exercise in normal subjects. Int J Obes (1989) 0.75
Effect of calcium chloride and 4-aminopyridine therapy on desipramine toxicity in rats. J Toxicol Clin Toxicol (1996) 0.75
Duchenne-Landouzy dystrophy: CT explanation of low serum creatinine level. AJR Am J Roentgenol (2000) 0.75
Nonreactive pupils due to monoamine oxidase inhibitor overdose. Crit Care Med (1987) 0.75
A simple method to minimize spillage on retrograde examination of the bowel in patients with an ileostomy or colostomy: technical note. Can Assoc Radiol J (2001) 0.75
Odontoid fracture following an epileptic seizure. Australas Radiol (2001) 0.75
Adaptation of the Müller method to allow quantitative characterization of the affinity and cross-reactivity of antibodies by competitive radioimmunoassay. Mol Immunol (1991) 0.75
The white chest. Chest (2001) 0.75
Rapid administration of high-dose human antibody Fab fragments to dogs: pharmacokinetics and toxicity. Fundam Appl Toxicol (1991) 0.75